and Eastern Cooperative Oncology Group–American College of Radiology Imaging Network, and their research staffs. We also thank USOR, NSABP, and NRG Oncology staff at the Operations and Biostatical ...

The NRG Oncology/Alliance clinical trial NRG-LU005, examining the addition of the immunotherapy drug atezolizumab combined with chemoradiation for patients with limited-stage small cell lung ...

Relevance section written by JCO Associate Editor Ingo K. Mellinghoff, MD. To our knowledge, NRG Oncology/RTOG1205 was designed as the first prospective, multi-institutional phase II randomized study ...

NRG Oncology, a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research ...

NRG Oncology Journal reference: Brown, P.D., et al. (2020) Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.

Results from the NRG Oncology Phase II NRG-GOG-0279 clinical study indicate that women with locally advanced squamous cell carcinoma of the vulva who received gemcitabine concurrently with ...

Results from the NRG Oncology RTOG 0631 clinical trial comparing stereotactic vs. conventional radiotherapy for localized vertebral metastases of the spine did not meet its primary endpoint.

Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy following radical hysterectomy and lymphadenectomy for ...

The NRG Oncology/GOG-263 study was conducted between 2010 and 2022 and involved 316 eligible patients with early-stage disease and intermediate-risk factors, including a combination of ...

chemoradiation in intermediate-risk, early-stage cervical carcinoma following radical hysterectomy and lymphadenectomy (results of NRG Oncology/GOG-263). Presented at: SGO Annual Meeting on Women ...